These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21570886)

  • 1. [Experience using doxorubicin-loaded DC Beads® during hepatic chemoembolisation].
    Muros-Ortega M; Díaz-Carrasco MS; Vila-Clérigues N; Mendoza-Otero F; de la Rubia A; Capel Alemán A
    Farm Hosp; 2011; 35(4):172-9. PubMed ID: 21570886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma].
    Sousa PF; Preto AS; Leão D; Madureira AM; Paquete J; Costa-Maia J; Vilares-Morgado P
    Acta Med Port; 2011; 24(1):29-36. PubMed ID: 21672439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization.
    Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ
    Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-Eluting Beads Loaded With Doxorubicin (DEBDOX) Chemoembolisation Before Liver Transplantation for Hepatocellular Carcinoma: An Imaging/Histologic Correlation Study.
    Pauwels X; Azahaf M; Lassailly G; Sergent G; Buob D; Truant S; Boleslawski E; Louvet A; Gnemmi V; Canva V; Mathurin P; Pruvot FR; Leteurtre E; Ernst O; Dharancy S
    Cardiovasc Intervent Radiol; 2015 Jun; 38(3):685-92. PubMed ID: 25342136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization using doxorubicin beads for unresectable hepatocellular carcinoma.
    Poston GJ
    Onkologie; 2010; 33(1-2):5-6. PubMed ID: 20164653
    [No Abstract]   [Full Text] [Related]  

  • 6. Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients.
    Dumortier J; Chapuis F; Borson O; Davril B; Scoazec JY; Poncet G; Henry L; Boillot O; Mion F; Berger F; Partensky C; Paliard P; Valette PJ
    Dig Liver Dis; 2006 Feb; 38(2):125-33. PubMed ID: 16389002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients.
    Malagari K; Chatzimichael K; Alexopoulou E; Kelekis A; Hall B; Dourakis S; Delis S; Gouliamos A; Kelekis D
    Cardiovasc Intervent Radiol; 2008; 31(2):269-80. PubMed ID: 17999110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).
    Dhanasekaran R; Kooby DA; Staley CA; Kauh JS; Khanna V; Kim HS
    J Surg Oncol; 2010 May; 101(6):476-80. PubMed ID: 20213741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of doxorubicin loaded beads in hepatocellular carcinoma.
    Muros-Ortega M; Díaz-Carrasco MS; Capel A; Calleja MÁ; Martínez F
    Int J Clin Pharm; 2013 Dec; 35(6):1105-12. PubMed ID: 23928684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.
    Malagari K; Alexopoulou E; Chatzimichail K; Hall B; Koskinas J; Ryan S; Gallardo E; Kelekis A; Gouliamos A; Kelekis D
    Abdom Imaging; 2008; 33(5):512-9. PubMed ID: 17938995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinoma.
    Boulin M; Ciboulet A; Guiu B; Maillard E; Bonnetain F; Minello A; Gagnaire A; Lepage C; Krause D; Hillon P; Bedenne L; Cercueil JP; Chauffert B; Jouve JL
    Dig Liver Dis; 2011 Nov; 43(11):905-11. PubMed ID: 21802381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients.
    Malagari K; Pomoni M; Spyridopoulos TN; Moschouris H; Kelekis A; Dourakis S; Alexopoulou E; Koskinas J; Angelopoulos M; Kornezos J; Pomoni A; Tandeles S; Marinis A; Rizos S; Kelekis D
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):774-85. PubMed ID: 21184228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.
    Nicolini A; Martinetti L; Crespi S; Maggioni M; Sangiovanni A
    J Vasc Interv Radiol; 2010 Mar; 21(3):327-32. PubMed ID: 20097098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
    Varela M; Real MI; Burrel M; Forner A; Sala M; Brunet M; Ayuso C; Castells L; Montañá X; Llovet JM; Bruix J
    J Hepatol; 2007 Mar; 46(3):474-81. PubMed ID: 17239480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin.
    Martin RC; Robbins K; Fagés JF; Romero FD; Rustein L; Tomalty D; Monaco R
    Breast Cancer Res Treat; 2012 Apr; 132(2):753-63. PubMed ID: 22200868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants.
    Namur J; Citron SJ; Sellers MT; Dupuis MH; Wassef M; Manfait M; Laurent A
    J Hepatol; 2011 Dec; 55(6):1332-8. PubMed ID: 21703190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local transcatheter arterial chemoembolization in the palliative treatment of inoperable hepatocellular carcinoma].
    Herszényi L; Farinati F; De Maria N; Marafin C; Cardin R; Del Prato S; Perini L; Naccarato R
    Orv Hetil; 1995 Mar; 136(12):643-7. PubMed ID: 7535908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: a multi-institutional registry.
    Martin RC; Rustein L; Pérez Enguix D; Palmero J; Carvalheiro V; Urbano J; Valdata A; Kralj I; Bosnjakovic P; Tatum C
    J Am Coll Surg; 2011 Oct; 213(4):493-500. PubMed ID: 21856182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of doxorubicin loading on response and toxicity with drug-eluting embolization in resectable hepatoma: a dose escalation study.
    Klass D; Owen D; Buczkowski A; Chung SW; Scudamore CH; Weiss AA; Yoshida EM; Ford JA; Ho S; Liu DM
    Anticancer Res; 2014 Jul; 34(7):3597-606. PubMed ID: 24982375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
    Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
    Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.